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ABSTRACT 
Introduction: Saliva has been described as the “mirror of the body”, reflecting the 
body’s general state of health. In cases of the hypofunction of the salivary glands, the 
harmony of the oral cavity and, consequently, of the organism, becomes 
compromised. In most cases, patients complain of xerostomia, itching, burning, and 
difficulty when speaking. The incidence of dry mouth and its public health impact are 
increasing and it can produce serious negative effects on the patient’s quality of life by 
affecting dietary habits, nutritional status, speech, taste, tolerance to dental prosthesis 
and varying severity injuries in the mucosa. 
Aim: The aim of this review was to evaluate the salivary gland hypofunction 
mechanisms, hypossalivation and altered saliva composition associated with 
xerostomia in the oral biochemistry. 
Materials and Methods: Clinical trials, research and review papers (1996 – 2012) were 
searched in PubMed, MedLine, Biomed and also in books available in the library of 
FMDUP. 
Development: Saliva is an aqueous, translucent fluid, with neutral pH, secreted by 
three paired extrinsic salivary glands: the parotid, submandibular, and sublingual 
glands, as well as hundreds of smaller intrinsic salivary glands that are distributed 
throughout the oral cavity. Saliva has a very complex composition, containing 
antimicrobial agents, immunoglobulins, electrolytes, components with buffer 
properties and proteins (S-IgA, mucins, lysozymes, histatins, lactoferrin and amylases). 
In digestive system, saliva has an important role in esophageal physiology, digestion, 
and protecting the gastric cells. The production of saliva occurs in 2 phases: The acinar 
fluid secretion and ductal fluid secretion, both controlled by autonomic nervous 
system. The major causes of xerostomia are objectively assessed salivary gland 
hypofunction, which could be attributed to radiation of head and neck cancer therapy 
and Sjögren syndrome. Some common problems associated with xerostomia, include 
oral candidiasis and dental caries. The management of xerostomia must be oriented by 
its etiology and directed towards the disease effects in the patient comfort and quality 
of life. 
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Conclusions: Xerostomia has a significant impact on the oral health. The management 
of this condition contributes positively to the restoration of patient welfare, since the 
treatment is directed towards symptomatic relief and prevention of complications 
originated from salivary decreased flow. Reliable diagnostic methods and effective 
new treatments are expected to lead to its complete cure in the near future. 
KEY-WORDS: Biochemical + xerostomia; biochemical + mechanisms + saliva, 
hypossalivation + mechanisms; hypossalivation + xerostomia 
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RESUMO 
Introdução: A saliva tem sido descrita como o "espelho do corpo", refletindo o estado 
geral de saúde. Quando existe hipofunção das glândulas salivares, a harmonia da 
cavidade oral e, consequentemente, do organismo, torna-se comprometida. Na 
maioria dos casos, os pacientes apresentam xerostomia, prurido, ardor e dificuldade 
na fala. A incidência de xerostomia e o seu impacto na saúde pública estão a aumentar 
e pode produzir graves efeitos na qualidade de vida do paciente, afetando os seus 
hábitos alimentares, estado nutricional, fala, paladar, tolerância à prótese dentária e 
lesões na mucosa oral. 
Objetivo: O objetivo desta revisão consiste em avaliar os mecanismos da hipofunção 
das glândulas salivares, hipossalivação e consequentes alterações na composição 
salivar, associados à xerostomia na bioquímica oral. 
Materiais e Métodos: Foi realizada uma pesquisa nas bases de dados PubMed, 
MedLine e Biomed sobre artigos referentes a ensaios clínicos, artigos de pesquisa e 
artigos de revisão, e ainda em livros disponíveis na biblioteca da FMDUP, entre 1996 e 
2012.  
Desenvolvimento: A saliva é um fluido aquoso, translúcido, com pH neutro, secretada 
por três pares de glândulas salivares extrínsecas: as glândulas parótidas, 
submandibulares, e sublinguais, bem como centenas de glândulas minor intrínsecas 
que estão distribuídas por toda a cavidade oral. A saliva tem uma composição muito 
complexa, contendo agentes antimicrobianos, imunoglobulinas, eletrólitos, 
componentes com propriedades tampão e proteínas (S-IgA, mucinas, lisozimas, 
Histatinas, lactoferrina e amilases). No sistema digestivo tem um papel importante na 
fisiologia esofágica, na digestão, e na proteção das células gástricas. A produção de 
saliva ocorre em 2 fases: a secreção acinar e secreção ductal, ambas controladas pelo 
sistema nervoso autónomo. As principais causas de xerostomia devem-se 
essencialmente à hipofunção das glândulas salivares, o que acontece nos casos em que 
há irradiação da cabeça e do pescoço na terapia do cancro e SS. Alguns problemas 
associados à xerostomia, incluem candidíase oral e cárie dentária. O tratamento desta 
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condição deve ser orientado pela etiologia e dirigida para os efeitos da doença no 
conforto e qualidade de vida do paciente. 
Conclusão: A xerostomia tem um impacto significativo sobre a saúde oral. O 
tratamento desta condição contribui positivamente para a restauração do bem-estar 
do paciente, uma vez que é orientado para o alívio sintomático e prevenção de 
complicações oriundas da diminuição do fluxo salivar. Métodos confiáveis de 
diagnóstico e novos tratamentos efetivos são esperados para levar à cura completa da 
xerostomia, num futuro próximo. 
PALAVRAS-CHAVE: Biochemical + xerostomia; biochemical + mechanisms + saliva, 
hypossalivation + mechanisms; hypossalivation + xerostomia 
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1. INTRODUCTION  
 
Saliva is the viscous, clear, watery fluid(1, 2) secreted from the parotid, 
submaxillary, sublingual and smaller salivary glands of the mouth(1, 3, 4) and it has 
been described as the “mirror of the body”, reflecting the body’s general state of 
health(5). In fact, it is now known that many substances found in peripheral blood are 
also found in saliva(5). That is why it is growingly considered as an essential, 
noninvasive diagnostic tool(3, 5) of hereditary disorders, autoimmune diseases, 
malignant and infectious diseases, and endocrine disorders, as well as in the 
assessment of therapeutic levels of drugs and the monitoring of illicit drug use(3). 
 
Saliva possesses many important functions:(1) it plays a  role in 
remineralization of teeth, maintains constant alkaline balance in the oral cavity(6), 
provides lubrication for mucous membranes, teeth  and food, regulates composition of 
the microflora of the oral cavity, and facilitates the functions of primary digestion, 
taste perception, and water balance control in the body(1, 6, 7). 
 
In cases of the hypofunction of the salivary glands, the harmony of the oral 
cavity and, consequently, of the organism, becomes compromised(6). Favorable 
conditions can be created for certain microflora to thrive and this heightens the 
probability of developing intensive caries, periodontal disease, candidiasis(6, 8-10), 
tooth loss(9, 10) and halitosis(8). In most cases, patients complain of oral dryness, 
itching, burning, and difficulty when speaking(6, 8), which are conducive to 
psychosomatic disorders. At this point, the so-called syndrome of multifactorial 
complex xerostomia or oral dryness develops(6). 
 
Xerostomia is the subjective feeling of mouth dryness, mainly caused by a low 
function of salivary glands, with decrease of saliva quality or quantity(8), with 
compromised biochemical properties(11). Xerostomia could be more adequately 
defined as oral dryness or deficient salivation, which impels the patient to seek 
treatment by turning to a specialist because of the abovementioned problems or 
sensations in the oral cavity(6). 
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The incidence of dry mouth and its public health impact are increasing due to 
the aging population, the effects of some systemic diseases, and medical management 
and commonly prescribed medications that reduce saliva production(10). Therefore, 
hyposalivation associated to these factors contributes to a number of health 
problems(11). Patients submitted to radiotherapy to treat head and neck cancer also 
present a significant reduction of salivary flow rate, buffering capacity and alterations 
in protein electrophoretic pattern, compared to healthy individuals(11).  
Hypossalivation can produce serious negative effects on the patient’s quality of 
life (physical, social and psychological consequences) by affecting dietary habits, 
nutritional status, speech, taste, tolerance to dental prosthesis and varying severity 
injuries  in the mucosa(8)  (Table I).  
 
 
Because of the consequences shown in table I, patients have tendency to 
avoid social contact and isolate themselves(8, 9), and these are important 
characteristics that must have to be evaluated in the therapeutic strategy(8).  
 
Table I - Clinical manifestations of Xerostomia(8) 
Oral Functional nature 
Chewing, swallowing, talking difficulties. Taste 
disturbances 
Oral Organic nature Caries, periodontal disease, plaque accumulation 
Mucosal Problems 
Atrophy, fissures and ulcers in soft tissues. Dry, 
erythematous and painfull mucosa. Burning sensation in 
tongue 
Infection Predisposition 
The reduction of antimicrobial function produces a change 
of pH, decrease of imunoglobulins, lisozyme and other 
enzymes, that carrying infections, especially to Candida 
albicans 
Halitosis 
Reduction of saliva, its lubrification functions and solvents 
determines the retention of food in oral cavity. 
Medication action and mucosal destruction causes 
halitosis 
Others 
In case of systemic diseases, xerostomia is accompanied 
with dryness of other mucosals, like xerophtalmia, 
dryness of nasal fossa, throat, genitals, skin, pharynx and 
respiratory tract 
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The diagnosis of xerostomia is mainly clinical. Mouth condition must be 
thoroughly evaluated(8). If justified, a quantitative evaluation of saliva secretion, in 
rest and under stimulation, might be done(8). This can enhance the perception of the 
patient complaints and assess in detail the state of the mouth(8) (Table II). 
Table II – Mouth State assessment(8) 
 
 Normal State Changes detected 
Saliva 
Clear, watery fluid, low 
viscosity 
Quantity, color, smell 
Lips 
Distended, smooth, soft, 
hydrated, pink 
Dry, inflamed, cracked, peeling, 
color 
Gums Pink, distended 
Bleeding, erythematous, 
inflamed, patches 
Tongue 
Red-pink, wet, slightly 
roughened, thin and pink 
papillae 
Dryness, excessive roughness, 
ulcers, patches and cracks 
Teeth 
White, aligned, without 
deposits 
Tooth absence, caries, color, 
restorations, sharp cusps, 
patches, maladaptive dental 
prosthesis 
Mucosa Pink, wet, smooth 
Inflamed, ulcers, nodules, 
color, patches, irritation 
 
The thorough knowledge of the salivary gland hypofunction mechanisms, 
hypossalivation and altered saliva composition associated with xerostomia(12), as well 
as the systemic and drug-induced etiology and the subsequent alterations in the oral 
cavity are crucial hallmarks in dentistry practice, as well as in several areas of general 
health(10). These skills contribute positively to the restoration of patient welfare(12), 
since the treatment is directed towards symptomatic relief and prevention of 
complications originated from salivary decreased flow, characteristic of 
xerostomia(10). 
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2. MATERIALS AND METHODS 
 
Clinical trials, research and review papers (1996 – 2012) were searched in 
PubMed, MedLine, Biomed and also books available in the library of FMDUP, using the 
following keywords:  
Biochemical + xerostomia; biochemical + mechanisms + saliva, hypossalivation + 
mechanisms; hypossalivation + xerostomia 
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3. SALIVA COMPONENTS AND FUNCTIONS 
 Saliva is an aqueous, translucent fluid, with neutral pH, secreted by the salivary 
glands into the oral cavity(2). It is currently known that it has an important role in 
maintaining normal physiological conditions of the tissues of the mouth(8). Saliva can 
be divided as gland-specific saliva and whole saliva(3, 4). Gland-specific saliva is 
collected directly from a gland. Whole saliva (mixed saliva) is a mixture of oral fluids 
and includes secretions from both the major and minor salivary glands, in addition to 
several constituents of non-salivary origin, such as gingival crevicular fluid, 
expectorated bronchial and nasal secretions, serum and blood derivatives from oral 
wounds, bacteria and bacterial products(3, 4), viruses and fungi, desquamated 
epithelial cells, other cellular components, and food debris(3). There are three paired 
extrinsic salivary glands in humans: the parotid, submandibular, and sublingual 
glands(1, 3-5), as well as hundreds of smaller intrinsic salivary glands that are 
distributed throughout the oral cavity, including the tip of the tongue(5, 13). 
Secretions from both the submandibular and sublingual salivary glands enter the oral 
cavity through Wharton's duct, and, thus, the separate collection of saliva from each of 
these two glands is difficult(3). Interestingly, the histological composition of the major 
extrinsic glands differs dramatically, with the larger parotid glands only containing 
serous cells and contributing to around 25% of total saliva(5). The submandibular 
glands, which account for approximately 70% of total salivary output, contain around 
equal amounts of serous and mucous cells. Finally, the sublingual glands contain 
mainly mucous cells and account for only 5% of total salivary output(5). Salivary flow is 
under direct and indirect control from the autonomic nervous system (sympathetic 
and parasympathetic)(3, 5, 8). Dramatically increased sympathetic stimulation can lead 
to reduced salivary flow and dry mouth(5). 
 
Saliva is mainly composed of water (95-99.4%)(3-5).The organic and inorganic 
molecules are dissolved in water, and their concentration may significantly vary 
between individuals, and in the same individual under various conditions(3, 4). Saliva 
has a very complex composition, containing antimicrobial agents, immunoglobulins, 
electrolytes (Na+, K+, Cl-, calcium, bicarbonate, phosphate) components with buffer 
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properties and proteins (S-IgA, mucins, lysozymes, histatins, lactoferrin and amylases) 
(8). The functions of saliva and the main molecules responsible for these functions are 
summarized in Table III(3). 
Table III – The Major Functions of Saliva(3)  
Functions Salivary Components involved 
Protective Functions 
Lubrication Mucins, prolin-rich glycoproteins, water 
Antimicrobial 
Amylase, complement defensins, lysozime, 
lactoferrin, lactoperoxidase, mucins, 
cystatins, histatins, proline-rich glycoproteins, 
secretory IgA, secretory leukocyte protease 
inhibitor, statherin, thrombospondin 
Growth Factors 
Epidermal growth factor (EGF), transforming 
growth factor-alpha (TGF-α), transforming 
growth factor-beta (TGF-β), fibroblast growth 
factor (FGF), insulin-like growth factor (IGF-I 
& IGF-II), nerve growth factor (NGF) 
Mucosal Integrity Mucins, electrolytes, water 
Lavage/cleansing Water 
Buffering Bicarbonate, phosphate ions, proteins 
Remineralization 
Calcium, phosphate, statherin, anionic 
proline-rich proteins 
Food and Speech-related Functions 
Food Preparation Water, mucins 
Digestion 
Amylases, lipase, ribonuclease, proteases, 
water, mucins 
Taste Water, gustin 
Speech Water, mucins 
 
Saliva has protective properties and contains a variety of antimicrobial 
constituents and growth factors(3). It possesses well- defined physical and chemical 
properties, such as high viscosity, low solubility, elasticity and adhesion, due to the 
chemical and structural characteristics of mucins, which are high molecular weight 
glycoproteins produced by sublingual, submandibular and palatines glands(4). Saliva 
lubricating action is a reflection of its viscosity which facilitates lip and tongue 
movements during feed, and it is also important for word articulation(4) and aids in 
the food digestion(3). The viscosity variation that saliva can present indicates 
important changes in its composition, particularly due to the levels of glycoproteins 
salivary secretion(4). 
 7 
 
Many of salivary glycoproteins interact with the tooth surface contributing to 
their protection and calcium fixation(8). Besides that, other glycoproteins, as is the 
case of s-IgA, can also inhibit microbial adhesion. Globally, mucins are large 
hydrophilic(8) glycoproteins that are highly viscous and relatively insoluble, two highly 
desirable qualities for a substance responsible for maintaining membrane integrity 
under harsh conditions(5). Mucins therefore protect the soft tissues of the oral cavity 
from dehydration and abrasion damage by forming a lubricating(5, 8) coating on 
tissues(5). They are also responsible for the selective adhesion of bacterial and fungal 
agents and may help to prevent biofilm formation(5, 8). Lysozyme is an enzyme that 
also has an antimicrobial activity, causing damage to the cell walls of bacteria by 
hydrolysis of peptidoglycan(8). It is present in different mucosal secretions, such as 
saliva and tears(5). However, Gram-negative bacteria, which contain 
lipopolysaccharides in their cell walls, are largely resistant to this type of agent(5). 
Histatins have antifungal function(8) and are secreted by the parotid and 
submandibular glands(5). Histatin 1, 3, and 5 are the major histatins detected in 
human saliva. Initially, histatin 1 was shown to inhibit hydroxylapatite crystal 
formation and was proposed to maintain the surface integrity of enamel(5). Later, the 
direct antimicrobial effects of histatins were investigated and shown to be limited to 
Candida albicans, with histatin 5 being the most potent agent(5). Together, these data 
suggested that histatins in parotid and submandibular gland secretions may play a 
major role in the primary innate defense mechanism. Moreover, the presence of a 
phosphorylated serine in histatin 1 suggests that it could be a precursor of the 
acquired enamel pellicle(5). Lactoferrin is a glycoprotein found, not only in milk, but 
also in various exocrine secretions, including saliva, and in various tissues(5). Its 
antimicrobial activity is one of the least controversial properties and although several 
modes of action have been suggested for this protein, an iron-scavenging function that 
prevents microbial growth is the most accepted(5). Lactoferrin was found to be 
present in saliva, with a marked elevation in the parotid secretion during the active 
phase of chronic recurrent parotitis (5). Inflammatory stimulation of lactoferrin 
expression suggests a basic protective mechanism in exocrine glands towards iron 
scavenging and microbial growth prevention(5).  
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In digestive system, saliva has an important role in esophageal physiology, 
digestion, and protecting the gastric cells(4, 8). In mouth, saliva participates in 
chewing, speech, swallowing, taste sensitivity, lubrication of the tissues, mucosal 
protection against invasion of certain substances(4, 8, 9) , antibacterial, antifungal and 
antiviral activity, post eruptive maturation, ionic balance regulation in the enamel 
remineralization,  acquired pellicle deposition and acid spread limitation(4, 8). 
Digestive components include α-amylase, which is involved in the conversion of 
polysaccharide carbohydrates, such as starch, into the polysaccharides maltose and 
dextrin, and lingual lipase secreted from the intrinsic salivary glands(5). Lingual lipase 
initiates the breakdown of lipids prior to food entry into the duodenum and works 
optimally at low pH(5). 
 In a dry mouth, natural remineralization and protection may not occur because 
of the lack of salivary calcium and phosphate ions(14). Salivary pH ranges from 6 (1, 11) 
to 7.4(1, 5, 8). The loss of its buffering capacity may cause oral pH to become acidic, 
dissolving calcium and phosphate ions from the enamel (as the pH falls below 5.5, 
demineralization starts to occur)(14). Changes in salivary flow rate may affect both the 
concentration and availability (mainly due to changes in salivary pH)(3) of salivary 
constituents. This may affect many factors that contribute to the development of 
caries, such as proliferation of acid-producing bacteria, inability to buffer the acid 
produced by bacteria or from ingested foods, loss of minerals from tooth surfaces and 
inability to replenish the lost minerals, and loss of lubrication(14). A low flow rate 
combined with a low or moderate buffer effect clearly indicates poor salivary 
resistance against microbial attack(12). The acquired enamel pellicle protects teeth 
from acid challenges by preventing direct contact between the acids and the 
enamel(14). It is an organic film covering the surfaces of teeth(12). Lipids, 
glycoproteins and proteins contained in saliva are the main components of dental 
pellicle, acting as a selectively permeable barrier to calcium and phosphate ions, but 
not to acids, which aids in the prevention of demineralization and in the promotion of 
teeth remineralization(14). Finally, salivary flow, even with food in mouth, prevents 
the accumulation of microbial particles and its potential harmful effects(7). 
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Saliva Production 
 
 Generally, salivary secretions have different characteristics depending on their 
origin. The parotid fluid has very low viscosity (low-mucin) and is mainly secreted 
during mastication – chewing saliva(7). Submaxillary fluid is a very viscous saliva (rich 
in mucin) and it is secreted especially when exists flavoring substances in the mouth - 
tasting saliva. Sublingual saliva has the same characteristics as the submaxillary, but 
more pronounced in terms of viscosity - swallowing saliva(7). 
 
Salivary glands are composed of specialized epithelial cells(3, 5), and their 
structure can be divided into two specific regions, the acinar and the ductal regions(3). 
The acinar region is where fluid is generated and most of the protein synthesis and 
secretion takes place. Aminoacids enter the acinar cells by means of active transport, 
and after intracellular protein synthesis, the majority of proteins are stored in storage 
granules that are released in response to secretory stimulation(3). 
 
 The production of saliva is an active process that occurs in 2 phases:  
  1) Primary secretion – occurs in the acinar cells. This results in a product 
 similar in composition and osmolality to plasma(15).  
  2) Ductal secretion – results in a hypotonic salivary fluid(15, 16), 
 because ductal epithelium is poorly permeable to water.(17) It also results in 
 decreased sodium and increased potassium in the end product. (15) (16) 
 
 The acinar fluid secretion includes the active transport of anions into the lumen 
and passage of water according to the osmotic gradient from the interstitial fluid into 
the salivary lumen(3). Acinar cells secrete a NaCl-rich fluid called primary saliva(17). 
The initial fluid is isotonic and is derived from the local vasculature(3). Acinar cells 
secrete fluid in a Cl--dependent manner. The coordinated activity of ion channels, 
water channels, pumps, cotransporters and exchangers results in the primary saliva 
formation(17).  
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 While acinar cells are water-permeable, ductal cells are not. However, ductal 
cells actively absorb most of the Na+ and Cl- ions from the primary salivary secretion 
and secrete small amounts of K+, HCO3
- and some proteins(15, 16). The primary 
salivary secretion is thus modified (NaCl reabsorption exceeds KHCO3 secretion)(17) 
and the final salivary secretion, as it enters the oral cavity, becomes hypotonic(3, 15, 
16). The degree of modification of saliva in the ducts heavily depends on the salivary flow 
rate. Fast rates result in a salivary product more like the primary secretion. Slow rates 
result in an increasingly hypotonic and potassium rich saliva(3). 
 
 In addition to the salivary glands morphological and functional heterogeneity, 
there are also important differences in the output regulatory mechanisms(7). The 
autonomic nervous system (sympathetic and parasympathetic) controls the salivary 
secretion(3, 8, 16). In a general way, parasympathetic stimulation by the production of 
acetylcholine excites the salivary glands and causes vasodilatation(7). Cholinesterase 
counteracts this effect(11). On the other hand, sympathetic stimulation causes 
vasoconstriction (11).  
Saliva secretion may be stimulated by psychic stimuli, including the thought, 
sight and smell of food, as well as the sound of cooking of some foods(13). The 
mechanical stimuli – those involving touch or pressure on oral structures and 
movements of the masticatory muscles and mandible – and those involving chemical 
substances that stimulate the taste receptors are also important players on saliva 
secretion.(13)   
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4. COMMON CAUSES OF XEROSTOMIA 
 Hypofunction of salivary glands, which results in qualitative and / or quantitive 
change of saliva(18), causing xerostomia, has multiple oral health consequences and 
affects quality of life(9). It may result from factors that affect the salivary center, the 
secretion of saliva and functional salivary gland changes(8). 
 
Factors that affect the salivary center 
 Emotions 
 The protein composition of human saliva depends on psycho-emotional state of 
individuals(19). Psychogenic causes, such as depression, anxiety, stress or fear, can 
also result in xerostomia(1, 9). Depression is usually accompanied by a decrease of 
proteins of molecular masses ranging from 20 to 200 kD, whereas emotionally positive 
intellectual activity cause the opposite effect. Due to these observations, it is 
suggested that human saliva may be used as an experimental model for the 
development of diagnostics of various psycho-physiological states(19).  
 
 Fasting 
 It must be observed that during fasting, the individual is subjected to 
psychological and physiological reactions to starvation, involving stress and behavioral 
changes(20). A short period of fasting therefore does not create persisting effects on 
the oral ecology. However, other extreme and longer-lasting conditions such as 
starvation, anorexia nervosa and some general diseases, can lead to intestinal 
malresorption and/or malnutrition. This might give longer lasting effects on saliva 
production and/or composition(20), causing xerostomia.  
 
 Menopause 
 Menopause is accompanied by a number of characteristic physical changes; 
some of which occur in the oral cavity(21). It seems that a positive relationship exists 
between ovarian hormone modifications and changes in the oral mucosa, and sex 
hormone withdrawal might be a cause in incidence of oral dryness feeling in 
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menopausal women(21). The exact mechanisms that cause sensation of oral dryness in 
menopausal women have not been firmly established. However, there are reports on 
amelioration of these symptoms by estrogen treatment(21).  
 
 Alzheimer’s disease 
 In cases of Alzheimer’s disease or stroke, patients may complain of dry mouth 
in the presence of normal salivary secretion due to altered perception(1, 9). 
 
Factors that affect the secretion of saliva 
  
 Tobacco 
 Dry mouth is often exacerbated by activities such as hyperventilation, breathing 
through the mouth, drinking alcohol(1) and smoking(1, 18, 22). Oral squamous cell 
carcinoma is the most common malignancy of the head and neck and it major inducer 
is exposure to tobacco. Cigarette smoke also contains oxidants such as oxygen and 
nitrogen free radicals and volatile aldehydes, known to increase oxidative stress in 
biological systems(23). Exposure of these molecules in cigarette smoke is probably the 
major cause of damage to biomolecules in saliva, such as α-amylase(23). Dehydration 
due to impaired fluid intake, emesis, diarrhea or polyuria can result in 
hyposalivation(1, 9).  
  
 Medications 
 Medications are the most common cause of decreased salivar function (1, 8, 9, 
18, 22) (table III). It has been reported that 80% of the most commonly prescribed 
medications cause xerostomia(9, 18). The drugs mostly responsible for dry mouth are 
tricyclic antidepressants, antipsychotics, atropinics, beta blockers and antihistamines, 
thus the complaint of dry mouth (1, 8, 22). It should be noted that, while there are 
many drugs that affect the quantity and/or quality of saliva, these effects are generally 
not permanent(1). 
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Table III – Drugs associated with dry mouth(9) 
Drugs that directly damage salivary glands 
Cytotoxic drugs 
Drugs with anticholinergic activity 
Anticholinergic agents: atropinics and 
hyoscine 
Antireflux agents: proton-pump 
inhibitors(e.g., omeprazole) 
Central-acting psychoactive agents 
Antidepressants, including tricyclic 
compounds 
Phenothiazines 
Benzodiazepines 
Antihistamines 
Bupropion 
 
Opioids 
Drugs acting on sympathetic system 
Drugs with sympathomimetic activity (e.g., 
ephedrine) 
Antihypertensives: alpha-1 antagonists (e.g., 
terazosin and prazosin); alpha-2 agonists (e.g., 
clonidine); beta blockers (e.g., atenolol, 
propanolol), which also alter salivary protein 
levels 
 
 
Drugs that deplete fluid 
Diuretics 
 
 
 
Function salivary gland changes 
 
 Radiation therapy 
 Hypossalivation is a common side effect of fractionated radiation therapy of 
head and neck(9), generally starting after 1000-2000 cGy, which corresponds to the 
second week of treatment(23). The degree of salivary gland damage depends on the 
number of salivary glands exposed to radiation and the dose. Radiation doses of 23 
and 25 Gy are the threshold, above which permanent salivary gland destruction 
occurs. After a high radiation dose (> 60 Gy), degenerative changes progress and the 
glands atrophy and become fibrotic(9). Patients often develop thick, sticky saliva(9, 23) 
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after starting head and neck radiotherapy, due to loss of serous secretion initially, 
followed by lack of any secretion and xerostomia(9). When major salivary glands are 
affected by radiation, salivary flow may decrease 90%. There is also a marked 
reduction in pH, due to a change in the concentrations of calcium, sodium and 
bicarbonatos(23).  
 Sjögren syndrome 
 Sjögren syndrome (SS) is the most common disease causing xerostomia in the 
elderly(1, 9, 18). It is an autoimmune chronic inflammatory disease with 
preponderance among females (female to male ratio 9:1)(1, 9) predominantly in 
postmenopause(1). The disease is characterized by lymphocyte infiltration of salivary 
and lacrimal glands resulting in hypofunction(1, 9). The disease can occur in 2 forms: 
primary, which involves the salivary glands, or secondary, which occurs along with 
other autoimmune disorders (mainly rheumatoid arthritis). Xerostomia and 
xerophthalmia are the main symptoms of primary SS(1, 9). Secondary SS also presents 
with symptoms of associated systemic conditions(9). 
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5. SALIVARY GLAND HYPOFUNCTION 
 The subjective symptom of xerostomia may not always correlate with salivary 
flow rates(10), because it can be caused by several medications without actually no 
reduction in salivary flow(24). For understanding this phenomenon, one should be 
aware that saliva enters the mouth at several locations, and that the different 
glandular secretions are not well mixed(10). For example, the contribution of parotid 
saliva to (un)stimulated whole saliva varies from site to site, ranging from being the 
major contributor to whole saliva collected buccally from the maxillary molars region, 
to being almost non-contributing to whole saliva collected in the incisor region(10). 
The wide variation in local contribution of the various salivary glands to whole saliva is 
also obvious when assessing mucosal wetness as the thickness of the salivary layer on 
the oral mucosa is much thinner in the labial and anterior hard palatal region than on 
the buccal mucosa and anterior tongue(10). These phenomena might explain, at least 
in part, the differences reported in the literature about level of hyposalivation and 
sensation of oral dryness(10).  
 
 The major causes of xerostomia are objectively assessed salivary gland 
hypofunction, which could be attributed to radiation of head and neck cancer 
therapy(11, 23) and several systemic conditions (11, 24). Diseases such as alcoholism, 
diabetes mellitus (type 1), malnutrition, anorexia nervosa, bulimia, viral or bacterial 
infections and medications used to treat HIV patients may cause parotid hypertrophy 
and consequences in salivary production and function(8). Salivary flow rate 
measurement is essential in diagnosing salivary gland hypofunction as the cause of 
xerostomia(24). In this context, it is important to note that salivary flow is inconstant, 
being more reduced in the morning, higher during the afternoon, and almost 
inexistent during the sleep (2). The daily volume of normal saliva production is around 
0,5 and 1,5 liters(8). Unstimulated saliva secretion is 0.3 ml/min and stimulated is 1.5 
ml / min. It is considered hyposalivation if values are lower than 0.1 ml/min and 0.7 
ml/min, respectively(8). 
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Radiation injury of salivary gland tissue 
  
 Clinical and biochemical alterations in the oral cavity and in the saliva can occur 
in patients exposed to radiotherapy(11). Irradiation of the salivary glands during the 
treatment of head and neck cancer results in a progressive loss of gland function 
(hyposalivation)(10, 11) beginning early in the course of radiotherapy(10). Radiation 
induces DNA damage, which can impair a proper cell division, resulting in cell death or 
senescence. As a consequence, this can promote changes in the quantity and in the 
composition of saliva(8, 10). Radiation injury leads primarily to the loss of saliva-
producing acinar cells, however interestingly, the ducts, although deprived of function, 
mostly remain intact(10). Nevertheless, several studies show no cell loss during the 
first days after irradiation, although saliva flow is dramatically reduced, and water 
secretion is selectively hampered(10). 
 Radiation-induced loss of salivary gland function occurs over four phases. The 
first phase (0–10 days) is characterized by a rapid decline in flow rate without changes 
in amylase secretion or acinar cell number(10). The second phase (10–60 days) consists 
of a decrease in amylase secretion paralleled by acinar cell loss(10). Reduction of the 
specific activity of the α-amylase indicates that radiation acts specifically on some 
proteins(11). Flow rate, amylase secretion and acinar cell numbers do not change in 
the third phase (60–120 days). In the fourth phase (120–240 days) further 
deterioration of gland function is seen, but this is accompanied by an increase in acinar 
cell number, albeit with poor tissue morphology(10).  
 
 Patient’s saliva after treatment is scarce(11), thicker and adhering(8), it means 
considerably more viscous, leading to oral discomfort(11). Palpation of the parotid 
papilla and milking of the gland and duct may reveal little or no saliva output(9). 
Hyposalivation occurs in almost 100% of cases after doses of radiation in excess of 50 
Gy(6). Serous glands are more radiosensitive than the mucinous(8, 10), but both glands 
have been shown to be sensitive to radiotherapy, at least with respect to their 
function(8).  
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6. COMMON ORAL COMPLICATIONS ASSOCIATED WITH XEROSTOMIA 
  
 Hypofunction of the salivary glands resulting from different etiologies can have 
different manifestations(6), affecting nutrition, oral health , as well as psychological 
health(1). 
  
 Some common problems associated with xerostomia, include a constant sore 
throat, burning sensation, difficulty in speaking and swallowing(1, 6, 9), hoarseness 
and/or dry nasal passages(1). It is well known that hyposalivation contributes 
considerably to disruption of the natural barrier of the oral mucous membranes(6). 
The dry mucosa is more susceptible to trauma and infection(1, 9) and may appear dry 
and shiny (Fig.1)(9).  
 
 
Oral Candidiasis 
 
 Although it is estimated that Candida species are present in the normal oral 
flora of healthy adults, certain conditions, like xerostomia, increase the risk of Candida 
overgrowth(25). Oral candidiasis is one of the most common oral infections seen in 
association with xerostomia(2). Extraoral findings include dry and cracked lips, which 
may be infected with Candida, and occasionally enlarged salivary glands(9). The clinical 
manifestations of candidiasis include angular cheilitis and erythematous candidiasis. 
Both are more common than pseudomembranous candidiasis, which is more readily 
recognized(9). It is characterized by adherent, curd-like plaques that can be removed 
by wiping firmly with a tongue blade or gauze(25).The tongue can become furrowed, 
dry and sticky or it can undergo partial or complete depapillation of the dorsum (Fig. 
2)(9). 
 A presumptive candidiasis diagnosis can usually be made based on the patient’s 
history, clinical presentation, and response to antifungal treatment. The diagnosis can 
be confirmed with a cytological smear of the lesion(25). 
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Dental Caries 
 
 The biggest cariogenic risk is resulted from salivary gland dysfunctions(18). An 
inadequate salivary flow changes the cleaning of teeth, carried by this fluid, by 
transporting the alimentary cariogenic substrates(26). The development of a dental 
cavity depends on various factors, such as the host condition, microbiota, time and 
diet(2). Microbiologically, the dental cavity may be defined as the interrelation 
between the oral cavity, bacteria and dental tissues; chemically, the processes 
involved in the formation of the cavity are described as interrelating pH and mineral 
flow and solubility on the tooth saliva interface(2). 
 
 Functions of saliva include the development of dental pellicle, a film that forms 
on tooth enamel and protects it against mineral loss from the tooth surface; 
replenishment of tooth surface minerals such as calcium and phosphate; the provision 
of antibacterial activity and buffering activity, which keeps oral pH neutral; and 
mechanical removal of residual food particles from the teeth(14, 26). In a dry mouth, 
natural remineralization and protection may not occur properly because of the lack of 
salivary calcium and phosphate ions(14). A lack of saliva exposes the teeth to acidic 
challenges from food and drinks, as well as to the acid produced by acidogenic 
bacteria(14). Acids dissolve calcium and phosphate ions from the enamel in a process 
called demineralization, which can eventually lead to cavities(14). Recurrent carious 
lesions are seen on the cervical margins or neck of the teeth, incisal margins and cusp 
tips (Fig. 3)(9).  
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7. MANAGEMENT OF HYPOSALIVATION 
 Patients with xerostomia should undergo frequent dental evaluations for early 
diagnosis of oral complications(9). They should be encouraged to carry out daily oral 
self-examinations for any mucosal ulcers, lesions or tooth decay and to report any 
unusual findings(9).  
 The management of xerostomia should begin with identification and 
management of the underlying cause(1, 8, 9), and it must be oriented by its etiology 
and directed towards the disease effects in the patient comfort and quality of life(8).  
 It is important that health workers explain to patients with xerostomia what are 
the best ways to get relieved and the measures to prevent its complications(8). 
 
Management of Salivary Flow and oral comfort  
 For patients with hyposalivation, the lack of saliva not only increases the risk of 
caries, but also creates an uncomfortable sensation of dryness. Oral products to treat 
dry mouth, which include toothpastes, mouthwashes with antibacterial enzymes, 
mouth sprays and liquids, among others, are helpful in the relief of the discomfort of 
xerostomia(14). For some patients, chewing gum can also help to increase salivary flow 
and increase mouth comfort(14). For patients who are able to chew gum, gums 
containing 100% xylitol are ideal, since xylitol cannot be fermented by acid-producing 
bacteria, so it helps to prevent caries(14) and can be easily incorporated into a 
patient’s routine(9).  
 
 If the salivary glands are not working properly but can still produce some saliva, 
some drugs help the glands to work better, or the use of artificial saliva can keep the 
mouth wet(1, 9). Parasympathetic drugs, such as pilocarpine(8, 14), bethanechol and 
the cholagogue anethole trithione (Sialor, Solvay Pharma Inc., ON) are used to 
stimulate salivary production in those with residual salivary-gland function and it can 
help to relieve oral dryness(14). Although these agents are effective sialogogues in 
patients with intact salivary glands, their efficacy is reduced in patients with changes in 
salivary glands due to radiation or disease(14).  
 20 
 
 Nowadays there is no definitive treatment for patients with dry mouth due to 
radiation therapy or SS, but high-potency fluoride treatment is recommended, and 
patients should be advised against using alcohol and tobacco(1, 9), as well as drinks 
with caffeine(1), and to adopt a low-sugar diet to control dental caries(9). In this cases, 
treatment is directed toward local and systemic salivary gland stimulation, 
symptomatic relief and preventing and treating complications due to 
hyposalivation(9). Stimulation of residual salivary secretory capacity by acupuncture 
has shown some promising results in head and neck radiotherapy patients(10). If saliva 
secretion cannot be stimulated, symptomatic treatment involves the use of saliva 
substitutes(1, 8, 9). Patients should be encouraged to take frequent sips of water 
throughout the day. Use of water during meals can aid in swallowing and improve 
taste perception(9). Use of bedside humidifiers, particularly at night, may lessen 
discomfort due to oral dryness(9). Commercially available saliva substitutes containing 
thickening agents, such as carboxymethyl cellulose or mucins, are the most 
common(9).  
 
 Taken together, dry mouth treatment will depend on what is causing the 
problem(27). Summarizing, if dry mouth is caused by medicine, the physician might 
change medicine or adjust the dosage, If salivary glands are not working right but can 
still produce some saliva, physicians or dentists might give a medicine that helps the 
glands to work better(27).  Also, the patient preference plays an important role in 
determining which products and procedures can be easily incorporated into a daily 
home care routine, and which offer the best relief for the symptoms of dry mouth(14).  
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8. CONCLUSIONS  
 
Saliva is an aqueous fluid produced by salivary glands. Its complex composition 
reflects the wide range of functions attributed to saliva. Indeed, it is involved in 
processes such as digestion, speech, as well as in teeth metabolism and defense 
against microorganisms. Deficiencies in saliva production and/or composition are 
defined as xerostomia. This pathological condition has a significant impact on the 
health of the patients, especially in their oral health.  
Since xerostomia often occurs in combination with a variety of other 
pathological conditions, and presents numerous etiologies(16) and multiple oral health 
consequences, it really affects the quality of life of the individuals.(9) The management 
of this condition should begin with the identification and the understanding of the 
underlying cause(1, 8, 9), and it must be oriented by its etiology and directed towards 
the disease effects(8), contributing positively to the restoration of patient welfare.(12) 
Nowadays there is no definitive treatment for patients with dry mouth(9), but reliable 
diagnostic methods and effective new treatments are expected to lead to its complete 
cure in the near future(16).  
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